상세 정보

underline
Metadata Downloads : dc(xml) or Excel
Cited 0 time in scopus ci

Title 

Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas

Authors 

J C KimS A RohD H ChoT W KimS N YoonC W KimC S YuSeon-Young KimYong Sung Kim

Publisher 

International Institute of Anticancer Research (IIAR)

Issue Date 

2009

Citation 

Anticancer Research, vol. 29, no. 8, pp. 3115-3124

Keywords 

Colorectal adenocarcinomachemotherapyresponsemolecular changes, tumorigenesis

Abstract 

Background: The canonical molecular changes in colorectal tumorigenesis were assessed for correlation with response to chemotherapy, in order to identify candidate markers. Patients and Methods: In total, 156 patients received adjuvant postoperative fluoropyrimidine-based chemotherapy and 32 patients received oxaliplatin- or irinotecan-based chemotherapy following palliative surgery or for metastatic or recurrent colorectal tumors. Representative molecular changes in tumor tissues, including adenomatous polyposis coli (APC) gene, wingless-type MMTV integration site family (Wnt), mismatch repair (MMR), RAF, transforming growth factor (TGF)-β, bone morphogenetic protein, and p53, had been previously determined, with an additional 42 patients included in this analysis. Results: The disease-free survival period (mean±SEM) was significantly longer after fluoropyrimidinebased adjuvant chemotherapy in tumors with TGF-β2 expression (42±1.4 vs. 21±4.7 months; p=0.005) and D18S46 loss of heterozygosity or microsatellite instability (45.7±1.5 vs. 40.5±1.4 months; p=0.048). In the metastatic settings, the high disease-control rate of oxaliplatin and irinotecan regimens correlated significantly with wild-type APC and intact MMR, respectively, relative to mutant APC and defective MMR (p=0.013, respectively). Interestingly, specific molecular steps of tumorigenensis were closely associated with particular toxicities. Conclusion: A subset of molecular changes occurring during colorectal tumorigenesis showed significant associations with therapeutic responses and toxicities to chemotherapy regimens, suggesting that these changes may be candidate predictors of chemoresponsiveness with further validation.

ISSN 

0250-7005

Appears in Collections

1. Journal Articles > Journal Articles

Registered Date

2019-05-02


There are no files associated with this item.
qrcode

FusionCharts.
DSpace Software Coptright(c) 2010 MIT and Hewleft-Packard  /  KRIBB-REPOSITORY ( Email:jakim@kribb.re.kr)